Masaru Muraoka
University of Yamanashi(JP)
Publications by Year
Research Areas
CAR-T cell therapy research, Lung Cancer Research Studies, Liver Disease Diagnosis and Treatment, Cancer therapeutics and mechanisms, Hepatocellular Carcinoma Treatment and Prognosis
Most-Cited Works
- → α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C(2013)250 cited
- → Engineered antibody Fc variant with selectively enhanced FcγRIIb binding over both FcγRIIaR131 and FcγRIIaH131(2013)128 cited
- → Changes in plasma vascular endothelial growth factor at 8 weeks after sorafenib administration as predictors of survival for advanced hepatocellular carcinoma(2013)67 cited
- Increased cell-substratum adhesion, and decreased gelatinase secretion and cell growth, induced by E-cadherin transfection of human colon carcinoma cells.(1995)
- → Association of Gene Expression Involving Innate Immunity and Genetic Variation in Interleukin 28B With Antiviral Response(2011)58 cited
- → Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibody(2018)56 cited
- → Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients(2013)52 cited
- → Hepatitis B virus (HBV)‐infected patients with low hepatitis B surface antigen and high hepatitis B core‐related antigen titers have a high risk of HBV‐related hepatocellular carcinoma(2018)49 cited
- → Specific Protein Delivery to Target Cells by Antibody-displaying Bionanocapsules(2008)38 cited
- → Deep Sequencing and Phylogenetic Analysis of Variants Resistant to Interferon-Based Protease Inhibitor Therapy in Chronic Hepatitis Induced by Genotype 1b Hepatitis C Virus(2015)31 cited